Camden Asset Management LP Has Decreased By $1.28 Million Its Kinder Morgan Del (KMI) Position; Livanova Plc Ord (LIVN) Shorts Down By 1%

February 17, 2018 - By Marguerite Chambers

Camden Asset Management LP decreased Kinder Morgan Inc Del (KMI) stake by 5.44% reported in 2017Q3 SEC filing. Camden Asset Management LP sold 67,400 shares as Kinder Morgan Inc Del (KMI)’s stock declined 10.34%. The Camden Asset Management LP holds 1.17 million shares with $22.48 million value, down from 1.24M last quarter. Kinder Morgan Inc Del now has $37.64B valuation. The stock decreased 1.44% or $0.25 during the last trading session, reaching $17.06. About 15.04M shares traded. Kinder Morgan, Inc. (NYSE:KMI) has risen 13.09% since February 17, 2017 and is uptrending. It has underperformed by 3.61% the S&P500.

Livanova Plc Ord (NASDAQ:LIVN) had a decrease of 1% in short interest. LIVN’s SI was 2.43M shares in February as released by FINRA. Its down 1% from 2.45M shares previously. With 354,500 avg volume, 7 days are for Livanova Plc Ord (NASDAQ:LIVN)’s short sellers to cover LIVN’s short positions. The SI to Livanova Plc Ord’s float is 5.52%. The stock increased 0.05% or $0.04 during the last trading session, reaching $85.85. About 275,064 shares traded. LivaNova PLC (NASDAQ:LIVN) has 0.00% since February 17, 2017 and is . It has underperformed by 16.70% the S&P500.




Among 4 analysts covering LivaNova (NASDAQ:LIVN), 2 have Buy rating, 0 Sell and 2 Hold. Therefore 50% are positive. LivaNova had 4 analyst reports since October 19, 2015 according to SRatingsIntel. The company was maintained on Thursday, November 3 by Canaccord Genuity. The company was initiated on Monday, October 19 by Piper Jaffray. The rating was reinitiated by WBB Securities on Wednesday, August 31 with “Hold”. The firm has “Buy” rating by Berenberg given on Wednesday, October 21.

LivaNova PLC, a medical device company, designs, develops, makes, and sells therapeutic solutions worldwide. The company has market cap of $4.14 billion. It operates in three divisions: Neuromodulation, Cardiac Surgery, and Cardiac Rhythm Management. It has a 73.69 P/E ratio. The Neuromodulation segment designs, develops, and markets vagus nerve stimulation therapy system, an implantable device for the treatment of drug-resistant epilepsy and treatment-resistant depression, as well as develops transcutaneous VNS devices.

Camden Asset Management LP increased Molina Healthcare Inc (Prn) stake by 9.63M shares to 10.53M valued at $13.19 million in 2017Q3. It also upped Verisign Inc (Prn) stake by 6.07 million shares and now owns 55.76 million shares. Citrix Sys Inc (Prn) was raised too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: